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Abstract 
Background 
The occupational therapy (OT) in care homes study (OTCH) aims to investigate the effect of 
a targeted course of individual OT (with task training, provision of adaptive equipment, 
minor environmental adaptations and staff education) for stroke survivors living in care 
homes, compared to usual care. 
Methods/Design 
A cluster randomised controlled trial of United Kingdom (UK) care homes (n = 90) with 
residents (n = 900) who have suffered a stroke or transient ischaemic attack (TIA), and who 
are not receiving end-of-life care. Care homes are randomised to either the intervention group 
(3 months of OT) or the control group (standard care). The primary outcome measure is 
independence in self-care activities of daily living (Barthel Activities of Daily Living Index). 
Secondary outcome measures are mobility (Rivermead Mobility Index), mood (Geriatric 
Depression Scale), preference based quality of life measured from EQ-5D and costs 
associated with each intervention groups. Quality adjusted life years (QALYs) will be 
derived based on the EQ-5D scores. Cost effectiveness analysis will be estimated and 
measured by incremental cost effectiveness ratio. Measurements are taken at baseline prior to 
randomisation and at 3, 6 and 12 months post randomisation. Staff training on facilitating 
independence and mobility and the use of adaptive equipment, will be delivered to every 
home, with control homes receiving this after the 12 month follow-up. Homes will be 
stratified by centre and by type of care provided and randomised (50:50) using blocked 
randomisation within strata to receive either the OT intervention or control (usual care). 
Allocation will be concealed from the independent assessors, but the treating therapists and 
residents will be unblinded from the intervention. 
Discussion 
This study will be the largest cluster randomised control trial of OT in care homes to date and 
will clarify the currently inconclusive literature on the efficacy of OT for stroke and TIA 
survivors residing in care homes. 
Trial registration 
ISRCTN00757750 
Keywords 
Stroke, Occupational therapy, Care homes, Randomised control trial, Cluster 
Background 
A systematic review and meta-analysis by Legg et al. [1] of nine trials (1258 participants) 
found that in stroke survivors, occupational therapy (OT) increased personal activities of 
daily living scores (i.e., standardised mean difference 0.18; 95% confidence interval 0.04 to 
0.32; p = 0.01). Furthermore, for every 100 people who received OT after a stroke, 11 (95% 
confidence interval 7 to 30) would be spared a poor outcome (i.e., death, deterioration in 
personal activities of daily living or dependency on others; Odds ratio 0.67; 95% confidence 
interval 0.51 to 0.87; p = 0.003). A care setting where OT might be particularly beneficial is 
in care homes, where 20% to 40% of all people newly admitted have stroke-related 
disabilities as their admittance diagnosis [2,3]. Generalisation of results from community 
studies should be treated with caution, as the characteristics of stroke survivors resident in a 
care home are likely to be different to those living in their own homes. For instance, 78% of 
residents in a care home have cognitive impairment, 76% need some form of assistance with 
ambulation and 71% are incontinent [2]. These factors might affect the capacity of care home 
residents to engage in OT. 
OT in care homes has been embraced in countries such as The Netherlands, where 93% of 
residents regularly receive this form of therapy [4], in contrast to the United Kingdom (UK), 
where as few as 3% of residents in care homes receive OT [5]. Over the last decade, the 
government in the UK has established a framework to assess eligibility and prioritise care 
needs of residents [6,7]. However, a recent audit of 112 care homes in the Midlands area of 
the UK found that only 6% of homes used the services of an OT at least once a week [8]. The 
under-utilisation of OT in this setting might be the result of staff being unaware of the role of 
an occupational therapist and/or how to access the services. Conversely, from a service 
commissioner’s perspective there is little evidence that the provision of OT services for care 
homes residents following a stroke is effective and/or cost-effective [8]. 
In the literature there is conflicting evidence on the efficacy of OT for on activities of daily 
life in care homes residents with stroke-related disabilities [9-11]. For instance, a study by 
Sackley et al. [9], which involved 249 care homes residents with mobility limitations, found 
that after a three month OT and physiotherapy programme there was no measureable 
improvements in functional independence and mobility. Although the findings suggest the 
therapy intervention to be ineffective, it could be argued that therapists in this study delivered 
interventions to maintain physical abilities of the residents rather than actively rehabilitate 
them. Furthermore, the therapy was applied relatively unselectively to all care home 
residents, rather than specifically targeted towards care homes residents with stroke-related 
disabilities. A cluster randomised trial, which evaluated the effect of OT compared to usual 
care over 3 months in 118 residents with a stroke-related disability at 12 care homes, found 
that residents who received OT were less likely to deteriorate in their ability to perform 
activities of daily living [10]. From baseline to 3 months the mean Barthel Activities of Daily 
Living Index (Barthel index) score had increased by 0.6 (SD = 3.9) in the intervention group, 
but decreased by 0.9 (SD = 2.2) in the control group. This equated to a difference between the 
groups of 1.5 and 95% confidence interval of -0.5 to 3.5 (allowing for a cluster design). The 
difference between the groups in Barthel index was maintained at 6 months (i.e., difference 
of 1.9 and 95% confidence interval of -0.7 to 4.4). The sample size was very small especially 
when taking into account the high intra class correction (ICC) of 0.37 (Barthel index at 
baseline), which is consistent with the ICC of 0.39 found in a subsequent pilot study of 
incontinence care in the same setting [11]. 
The findings from these studies demonstrate that even modest levels of OT may have 
detectable and lasting effects on morbidity and possibly mortality. It would, therefore, be 
appropriate to replicate the study with a larger sample to investigate the clinical impact of OT 
on activities of daily life in care homes residents with stroke-related disabilities. 
In addition to the investigation of clinical impact of OT, a larger sample size will enable a full 
assessment of the economic impact that OT has on providing health care. Previous work in 
Canada [12] and in the UK [13] investigated the cost of OT in care homes, based on cost-
consequence analyses. The Canadian study studied two types of OT and physiotherapy 
intensities, which compared 1 therapist to 50 bed ratio to 1 therapist to 200 bed ratio. 
Improvements in functional outcome measures favoured OT and physiotherapy delivered at 
the 1:50 ratio, which resulted in reduced direct nurse time and equated to an annual saving of 
283 Canadian dollars per resident [12]. The study conducted in the UK, examined the effect 
of OT on levels of depression and quality of life in care homes residents [13]. It was found 
that, at 2005 levels, the net cost of providing the OT service was 16 British pounds per 
resident per week. However, it was suggested by the authors that OT might have resulted in a 
reduction in overall health costs [13]. Both studies suggest that providing OT to residents in a 
care homes incurs an initial cost to health care providers, but generates savings in the long-
term through the improvement of functional outcomes of residents without stroke-related 
disabilities [12,13]. There is, therefore, a need to analyse the economic impact of OT on 
residents with stroke-related disabilities in care homes. 
The purpose of this study is to conduct a large scale cluster randomised control trial to 
evaluate the effects of the provision of OT, which include task related training, the provision 
of adaptive equipment, minor environmental adaptations and staff education, compared to 
usual care, on activities of daily living, mobility, depression and quality of life for residents 
with stroke-related disabilities in care homes. Allocation of therapy cannot be concealed from 
the carers and/or residents so, to minimise contamination of intervention, the unit of 
randomisation will be the care home. Furthermore, we aim to conduct a health economic 
evaluation of the effect of the provision of OT services has on the health care system 
compared to usual care. Given the findings of previous studies on clinical [1,9-11] and health 
economic [12,13] impact of OT compared to usual care in the UK [5,8], it is hypothesised 
that the provision of OT services will have a favourable impact on activities of daily living, 
and reduce long-term costs to health care providers. 
Methods/Design 
Design 
This study is a pragmatic stage III cluster randomised controlled trial with health economic 
evaluation. The flow diagram for this trial is presented in Figure 1. and follows the 
CONSORT extension for cluster randomised trials [14]. 
Figure 1 Flow diagram of the progress of clusters and individuals through phases of the 
trial 
Setting 
Care homes for older people in the UK from Birmingham, Bangor, Coventry, Portsmouth, 
Nottingham, Central Lancashire, Peninsula, Staffordshire and Wolverhampton areas. We will 
include all funding models of homes (i.e. private, charitable, not for profit and local 
authority). Homes for people with learning disabilities or drug addiction will be excluded 
from the study. 
Recruitment and consent 
Care homes 
Care home managers will be approached and provided with information about the study. 
They will be given a full oral explanation of the study, a leaflet describing OT and study 
information sheets. Care home managers will be asked to give written agreement for their 
home to participate in the study. Following this, residents will be recruited individually. 
Residents 
Care home managers will assist to identify potential participants. Participants must be 
resident in a care home and have a history of stroke or transient ischaemic attack (TIA). All 
efforts will be made to include participants with communication and cognitive impairments, 
because this will more accurately reflect the population characteristics. Participants will be 
excluded from the study if they are receiving end-of-life care (with life expectancy < 6 
months). Care home members of staff will search residents’ notes to determine a diagnosis of 
stroke or TIA. If required, we will confirm this diagnosis with general practice records. When 
a potential participant is identified as being eligible for the study, they and (where 
appropriate) their family (outlined in the UK’s Mental Capacity Act 2005 [15]) will be 
approached by a senior member of the care home staff, a research network nurse or therapist, 
general practitioner or geriatrician, and will be asked if they are interested in participating in 
a research study. Prospective participants (and their family) will be given a full explanation 
of the study. This will include discussion of the treatment options in the trial and the manner 
of treatment allocation. Potential participants and their family will be given a participant 
information sheet, or a consultee information sheet and the UK Clinical Research Network’s 
2007 [16] publication on ‘Understanding Clinical Trials’ to read. They will be given 
sufficient time to decide (at least 24 hours) whether they would like to join the study. This 
may take a few days if relatives only visit at weekends for example. Residents will then be 
asked to sign the consent form. If the resident is considered to be incapacitated, according to 
the Mental Capacity Act 2005 guidelines [15], a family member (consultee) will be 
approached for consent. The participant’s general practitioner will be informed, if the patient 
or consultee consents, in writing of their participation in the trial. Research nurses from NHS 
research networks will assist in the recruitment and consent processes. 
Randomisation 
Homes and participants will be recruited and consented into the study before the 
randomisation process commences to reduce bias [17,18]. Homes will be stratified by 
residential care homes providing personal care and homes providing additional nursing care. 
Once the study co-ordinator (KES) receives confirmation from the assessors that all residents 
in a participating home have given their consent and completed a baseline assessment, the 
homes will be grouped and randomised (50:50) to receive either the OT intervention or 
control (usual care). The assignment of cluster to either the OT intervention or control arm of 
the study will be conducted by the study co-ordinator. They contact the managers of the 
homes directly and make arrangements for the occupational therapist to visit the care home to 
commence the intervention. The allocation sequence will be generated by a statistician 
(AKR) using blocked randomisation within strata (centre and type of home; residential, 
nursing) at the Primary Care Clinical Research and Trials Unit at the University of 
Birmingham, independent from the research team. The details of the sequence will be 
unknown to any of the assessors or to the study co-ordinator. Allocation will be concealed 
from the independent assessors, but it is not possible to mask the treating therapists or 
residents from the intervention. The success of blinding will be evaluated at each follow-up 
stage by asking the assessors to record if the allocation has been revealed to them. 
Intervention 
We developed an OT intervention package for residents in a care home using evidence and 
consensus from a previous study [19]. The OT intervention will be provided by qualified 
occupational therapists and assistants and will be targeted towards improving independence 
in activities of daily living, such as feeding, dressing, toileting, bathing, transferring and 
mobilising. Adaptive equipment will be provided as part of the study and will include 
personal items, such as adapted cutlery and walking aids. Furthermore, adaptations to the 
individual's environment might need to be made, such as chair raisers, bed levers, raised toilet 
seats or grab rails. When adaptive equipment or adaptations to the environment have been 
provided to the resident, the occupational therapist will demonstrate to them and the care staff 
how to use the equipment effectively, whilst adhering to safety regulations. The frequency 
and duration of the OT will be dependent on the resident and therapist’s agreed goals (within 
the framework of the home). In the pilot study, the number of face-to-face sessions ranged 
from 1 to 25 per resident over a three-month period (median time = 8.5 hours and mean 
time = 4.7 hours), dependent on the individual needs of the resident [19]. The OT intervention 
will follow a ‘client centred approach’ [20] and will include a continuous process of 
assessment, treatment and reassessment. In line with current evidence on effective treatment, 
the OT intervention will adopt a task-specific training approach [21]. Treatment logs have 
been developed in which the dose and focus of OT intervention can be documented. This will 
allow for accurate costing for health care services to residents in care homes to be calculated. 
Care homes in the control arm of the study will continue to provide their usual care to 
residents (i.e. continue providing (or not) any therapy as they would do usually). 
Training for care home staff 
Specific training will be given for staff involved in the care of the residents receiving active 
therapy. In addition, all intervention homes will be offered a group training session on the 
key principles of OT by the occupational therapist. A half-day group training session for care 
home staff has been developed and summarised, on the facilitation of independent daily 
living activities and mobility of residents [22]. 
Care homes in the control arm will receive similar training, but only after the 12 month 
follow-up assessment has been completed. It is anticipated that delivering the training to the 
control group will facilitate compliance and reduce loss to follow-up in the control group. 
This, in turn, will reduce the potential bias during the follow-up period [19]. 
Outcome measures 
Demographic data 
Information recorded by a member of staff from the care home about the resident will include 
age, gender, current medication intake and date, type and side of stroke. Furthermore, at 
baseline a trained assessor will administer the Sheffield Screening Test for Acquired 
Language Disorders, to assess receptive/expressive aphasia [23], and the mini mental state 
examination to assess cognitive function [24]. Finally, data on resource use will be recorded 
through logs and collected from health and social care services to conduct a health economic 
evaluation for both interventions delivered during this study. 
Primary outcome measure 
The primary outcome measure is the Barthel Activity of Daily Living Index [25], which is a 
commonly used measure of independent self-care in people who survived a stroke [26,27]. 
Furthermore, the Barthel index assesses specific aspects of self care targeted by the therapy. 
A change of two points on this scale is widely accepted as being clinically meaningful [28]. 
The Barthel index can be completed by the resident or with assistance from a member of 
staff. 
Secondary outcome measures 
Secondary outcome measures will assess mobility, mood, safety, quality of life and costs. 
Mobility will be assessed with the Rivermead mobility index [29], which is a 15-item 
measurement of functional mobility. The geriatric depression scale [30] will be administered 
to measure mood. The full 30-item version will be used as standard, but in cases where 
residents are unable to self complete or follow and interview the informant version will be 
filled out. Quality of life is measured by the EQ-5D [31], which is a well established measure 
for evaluating patients preference. Costs will be estimated based on resource usage log and 
weighted by unit costs. This will include visits to hospital and include in- and out-patient 
appointments, allied health professionals time, general practitioner visits, provision of care in 
a care home, adaptive equipment, minor environmental adaptations and staff education. Unit 
costs will be obtained from the national health and social care services reference costs and 
personal social services research unit [32]. Additionally, any adverse events will be recorded 
in participant logs and will include a fall or equipment failure leading to an injury requiring a 
visit to a hospital or general practitioner. 
Assessment schedule 
An overview of the assessment schedule is given in Table 1. Baseline assessments will be 
conducted prior to randomisation to reduce possible recruitment bias repetition [33]. The 
primary measurement point will be at 3 months after randomisation and follow-up 
assessments will be conducted at 6 and 12 months prior to randomisation. Data will be 
collected from participants where they are currently residing. If a participant moves to 
another home between assessments, then the assessors will attempt to collect follow-up data. 
Table 1 Proposed assessment schedule 
Assessment Time of administration 
Baseline 3 months 6 months 12 months 
Demographics ✓    
Sheffield Screening Test* ✓    
Mini Mental State Examination ✓    
Barthel Activity of Daily Living Index ✓ ✓ ✓ ✓ 
Rivermead Mobility Index ✓ ✓ ✓ ✓ 
Geriatric Depression Scale ✓ ✓ ✓ ✓ 
EQ-5D ✓ ✓ ✓ ✓ 
Resource Use Log  ✓ ✓ ✓ 
Adverse Event Log  ✓ ✓ ✓ 
*Full name of the test is Sheffield Screening Test for Acquired Language Disorders 
Sample size 
A sample of 330 residents in each arm will be sufficient to identify a clinically meaningful 2-
point change in the Barthel index. This estimate is based on a standard deviation of 3.7 [10], 
90% power, 5% level of significance and an ICC of 0.4 [10,11]. Given that the trial will be a 
cluster randomised trial, it is predicted that 33 homes with 10 residents in each will be 
required in each arm of the study. Based on the attrition rate of 26% from a previous study 
[10], it is predicted that 45 homes with 10 residents in each will be required in each arm of 
the study (i.e., 900 residents in total). 
Statistical analysis 
Baseline characteristics of participants will be tabulated by treatment arm. Items will include 
demographic details of residents, past medical history, questionnaires; and breakdown of the 
number of care homes and cluster size. 
Primary analysis 
The primary outcome is the mean Barthel index score at the 3 month follow-up. A mixed 
model analysis will be used to compare Barthel index scores between the intervention and 
control groups. The primary analysis will be adjusted by care home (as a random factor), 
baseline Barthel index score, and stratification factors: centre and type of care home (nursing, 
residential). Participants that die before their follow-up date will be given a Barthel index 
score of zero at all subsequent follow-ups. In addition, participants will be categorised into 3 
outcome groups based on an individual’s change in Barthel index score at 3 months from 
baseline (below 0 or death = ‘poor’, 0 to 1=’moderate’, 2 and above=’good’). A non-linear 
mixed effects model will be used to compare this ordinal outcome between the groups. 
Adjustments will be made for care home (random), centre and type of care home (fixed). 
Secondary analysis 
To identify any longer term effects, a repeated measures mixed model analysis of the primary 
outcome will be undertaken, comparing groups across all time points. The analysis will 
include adjustment for care home (as a random factor), baseline Barthel index score, and 
stratification factors: centre and type of care home. Similar analyses will be performed for 
mobility, mood and quality of life. 
The number of falls will be compared using a Poisson or negative binomial model, with 
adjustments for care home, centre and type of care home as previously described. A 
sensitivity analysis of the outcomes will be performed to examine the potential effect of 
missing data. This will include best case, worst case and multiple imputation methods. 
Analysis will be by intention to treat, whereby residents will be analysed according to the 
intervention to which they are randomised, regardless of whether they comply with the 
treatment. All participants irrespective of when they die, withdraw or are lost will be included 
in the arm to which they were randomised, including those that die after consent but prior to 
randomisation. Those participants that move home will be analysed by the home they were 
originally randomised to. Analyses will be performed using Stata (StataCorp,. Texas, USA) 
and SAS software (SAS Institute Inc., Cary, NC). 
Health economic evaluation 
Outcomes from health economic evaluation analyses will establish cost effectiveness of a 
treatment expressed as incremental cost per quality-adjusted life-years (QALYs) gained. 
Generalised linear models will be used to investigate differences between interventions for 
QALYs and costs. Bootstrap methods will be adopted to produce incremental cost 
effectiveness ratio and associated confidence intervals. Cost-effectiveness acceptability 
curves will be generated to reflect the probability that a treatment will be cost effective given 
a society’s willingness to pay in terms of price per QALY gained. 
Governance 
Ethical approval 
Favourable ethical opinion for this study was obtained from the National Research Ethics 
Service, Coventry Research Ethics Committee (Reference: 09/H1210/88). The study was 
granted an International Standard Randomised Controlled Trial Number (00757750). 
Trial management 
A trial steering group has been established to monitor the governance of the study consisting 
of the main research team, an independent chair, a geriatrician, an occupational therapist, a 
physiotherapist with expertise in rehabilitation research a patient representative, and a 
representative from the National Institute for Health Research. A data monitoring committee 
has been established with an independent geriatrician as chair, a statistician and an 
occupational therapist. During the development of this protocol, a patient representative was 
consulted. 
Service user involvement 
Service user (and carer) involvement will be incorporated at all levels of this study. Service 
user (and carer) involvement will not be a ‘stand-alone’ activity but rather an integral part of 
all aspects of this study. Service users (and carers) will be directly involved as research 
‘partners’ and not just as ‘data providers’. All support for service users (and carers) 
involvement will be provided by the Stroke Research Network members who have expertise 
in training and supporting service users (and carers) for involvement in National Health 
Service research, service evaluation and development. 
Discussion 
The methodological limitations and considerations of cluster randomised trials are well 
reported [34] and have been addressed in the current study protocol. Furthermore, the choice 
of clustering design to reduce intervention contamination was a key component of the 
development of this trial. Previous cluster randomised trials demonstrated that a relatively 
small level of OT may have detectable and relatively long-lasting effects on morbidity and 
possibly mortality in care homes residents with stroke-related disabilities [10,11]. These 
studies enrolled small numbers of clusters and participants and were conducted in specific 
areas of the UK, which reduces the generalisability of the findings to residents in care homes 
more widely. The current study will be the largest cluster randomised control trial of OT in 
care homes to date. It will provide clinically relevant information on the effect of OT services 
on activities of daily life compared to usual care. Furthermore, it aims to establish the effects 
of OT services on aspects such as mobility, depression and quality of life, which are major 
challenges experienced by many residents [2]. Finally, this study will evaluate the health 
economic impact of OT services compared to usual care. In combination, the findings of this 
large scale cluster randomised controlled trial will assist in the formulation of UK guidelines 
and policies on the provision of OT services for residents with stroke-related disabilities in 
care homes. 
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